A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

J R Brown; J Abramson; E Hochberg; E Mikler; V Dalton; L Werner; H Reynolds; C Thompson; S M McDonough; Y Kuang

doi:10.1038/leu.2010.199

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

Identifier:nobleid.org/w1/20260515/FEE29AB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FEE29AB3.svg?ark=w1%2F20260515%2FFEE29AB3)](https://nobleid.org/work/w1/20260515/FEE29AB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL.

Identifier:nobleid.org/w1/20260515/FEE29AB3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FEE29AB3.svg?ark=w1%2F20260515%2FFEE29AB3)](https://nobleid.org/work/w1/20260515/FEE29AB3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work